insights_auto
Why is PGEN down 2,35%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
US$7,48
arrow_downward
-2,35%(-0,18) 1D
US$7,55
arrow_upward
+0,94% (+0,070)bedtimeAfter hours
Closed: 13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
US$7,60
High
US$7,71
Low
US$7,48
Mkt. cap
2,68 ຕື້
Avg. vol.
4,74 ລ້ານ
Volume
2,40 ລ້ານ
52-wk high
US$8,98
52-wk low
US$3,04
EPS
US$-1,10
Beta
0,92
Shares outstanding
358,04 ລ້ານ
No. of employees
160
Open
US$7,60
High
US$7,71
Low
US$7,48
Mkt. cap
2,68 ຕື້
Avg. vol.
4,74 ລ້ານ
Volume
2,40 ລ້ານ
52-wk high
US$8,98
52-wk low
US$3,04
EPS
US$-1,10
Beta
0,92
Shares outstanding
358,04 ລ້ານ
No. of employees
160
News stories
From web sources and news partners
Yahoo Finance
·
1 ມື້ກ່ອນ
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
Founded21 ພ.ພ. 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com